189 related articles for article (PubMed ID: 28535360)
21. Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features.
Pickhardt PJ; Siegel MJ; Hayashi RJ; Kelly M
Radiology; 2000 Oct; 217(1):16-25. PubMed ID: 11012419
[TBL] [Abstract][Full Text] [Related]
22. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
Taylor AL; Marcus R; Bradley JA
Crit Rev Oncol Hematol; 2005 Oct; 56(1):155-67. PubMed ID: 15979320
[TBL] [Abstract][Full Text] [Related]
23. Otolaryngologic management of posttransplant lymphoproliferative disease in children.
Sculerati N; Arriaga M
Ann Otol Rhinol Laryngol; 1990 Jun; 99(6 Pt 1):445-50. PubMed ID: 2350129
[TBL] [Abstract][Full Text] [Related]
24. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
Khedmat H; Taheri S
Ann Transplant; 2011; 16(1):109-16. PubMed ID: 21436784
[TBL] [Abstract][Full Text] [Related]
25. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ
Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052
[TBL] [Abstract][Full Text] [Related]
26. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.
Chiereghin A; Prete A; Belotti T; Gibertoni D; Piccirilli G; Gabrielli L; Pession A; Lazzarotto T
Transpl Infect Dis; 2016 Feb; 18(1):44-54. PubMed ID: 26574232
[TBL] [Abstract][Full Text] [Related]
27. Autopsy pathology of pediatric posttransplant lymphoproliferative disorder.
Collins MH; Montone KT; Leahey AM; Hodinka RL; Salhany KE; Belchis DA; Tomaszewski JE
Pediatrics; 2001 Jun; 107(6):E89. PubMed ID: 11389287
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous giant cell plasmacytoma in an organ transplant recipient: a rare presentation of a posttransplant lymphoproliferative disorder.
Wang E; Stoecker M
Am J Dermatopathol; 2010 Jul; 32(5):479-85. PubMed ID: 20414094
[TBL] [Abstract][Full Text] [Related]
29. Posttransplant lymphoproliferative diseases.
Gross TG; Savoldo B; Punnett A
Pediatr Clin North Am; 2010 Apr; 57(2):481-503, table of contents. PubMed ID: 20371048
[TBL] [Abstract][Full Text] [Related]
30. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
[TBL] [Abstract][Full Text] [Related]
31. Pattern analysis of Epstein-Barr virus viremia and its significance in the evaluation of organ transplant patients suspected of having posttransplant lymphoproliferative disorders.
Cho YU; Chi HS; Jang S; Park SH; Park CJ
Am J Clin Pathol; 2014 Feb; 141(2):268-74. PubMed ID: 24436276
[TBL] [Abstract][Full Text] [Related]
32. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.
Montone KT; Friedman H; Hodinka RL; Hicks DG; Kant JA; Tomaszewski JE
Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104
[TBL] [Abstract][Full Text] [Related]
33. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
[TBL] [Abstract][Full Text] [Related]
34. Update on posttransplant lymphoproliferative disease.
Martin-Moreno PL; Panizo C
Curr Opin Nephrol Hypertens; 2018 Nov; 27(6):440-444. PubMed ID: 30157079
[TBL] [Abstract][Full Text] [Related]
35. Posttransplant lymphoproliferative disorder presenting in the head and neck.
Lattyak BV; Rosenthal P; Mudge C; Roberts JP; Renze JF; Osorio RW; Emond JC; Lalwani AK
Laryngoscope; 1998 Aug; 108(8 Pt 1):1195-8. PubMed ID: 9707243
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
Oertel S; Trappe RU; Zeidler K; Babel N; Reinke P; Hummel M; Jonas S; Papp-Vary M; Subklewe M; Dörken B; Riess H; Gärtner B
Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109
[TBL] [Abstract][Full Text] [Related]
37. Posttransplant lymphoproliferative disorder in pediatric patients: Survival rates according to primary sites of occurrence and a proposed clinical categorization.
L'Huillier AG; Dipchand AI; Ng VL; Hebert D; Avitzur Y; Solomon M; Ngan BY; Stephens D; Punnett AS; Barton M; Allen UD
Am J Transplant; 2019 Oct; 19(10):2764-2774. PubMed ID: 30884098
[TBL] [Abstract][Full Text] [Related]
38. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.
Gibson SE; Picarsic J; Swerdlow SH; Pantanowitz L
Cancer Cytopathol; 2016 Jun; 124(6):425-35. PubMed ID: 26992116
[TBL] [Abstract][Full Text] [Related]
39. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
40. Posttransplant lymphoproliferative disorder of the central nervous system.
Kempf C; Tinguely M; Rushing EJ
Pathobiology; 2013; 80(6):310-8. PubMed ID: 24013167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]